![Laurie Alsup](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurie Alsup
Direktor/Vorstandsmitglied bei
THERAVANCE BIOPHARMA, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Laurie Smaldone Alsup is currently Director at Arvinas Operations, Inc., Independent Director at Theravance Biopharma, Inc. since 2018, Independent Director at Arvinas, Inc. since 2019, and Senior Vice President-Regulatory Science at NDA Group AB since 2023.
Former roles include President & Chief Executive Officer at Phytomedics, Inc. from 2008 to 2012, Independent Director at Humanigen, Inc. in 2015, Lead Independent Director at Pardes Biosciences, Inc. from 2022 to 2023, Director at Kalobios Pharmaceuticals, Inc. from 2013 to 2015, Independent Director at Kinnate Biopharma, Inc. from 2020 to 2024, Independent Director at BlackBerry Ltd. from 2015 to 2024, President & Chief Scientific Officer at PharmApprove LLC from 2011 to 2016, and VP-Corporate Strategy & Business Risk Management at Bristol Myers Squibb Co. from 2004 to 2007.
Education includes undergraduate studies at Fordham University and a doctorate from Yale School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
THERAVANCE BIOPHARMA INC 0,16 % | 12.06.2026 | 80.989 ( 0,16 % ) | 1 Mio $ | 31.05.2026 |
ARVINAS, INC. 0,06 % | 24.06.2026 | 41.572 ( 0,06 % ) | 373 317 $ | 31.05.2026 |
Aktive Positionen von Laurie Alsup
| Unternehmen | Position | Beginn |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 13.02.2018 |
| ARVINAS, INC. | Direktor/Vorstandsmitglied | 20.11.2019 |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services Provides regulatory and drug development consulting services | Corporate Officer/Principal | 01.08.2023 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Laurie Alsup
| Unternehmen | Position | Ende |
|---|---|---|
| BLACKBERRY LIMITED | Direktor/Vorstandsmitglied | 25.06.2024 |
| KINNATE BIOPHARMA INC. | Direktor/Vorstandsmitglied | 03.04.2024 |
| PARDES BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 30.08.2023 |
PharmApprove LLC
 PharmApprove LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies | Präsident | 01.03.2016 |
| HUMANIGEN, INC. | Direktor/Vorstandsmitglied | 20.11.2015 |
Ausbildung von Laurie Alsup
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
BlackBerry Ltd.
 BlackBerry Ltd. Packaged SoftwareTechnology Services Provides intelligent security software services for mobile communications | Technology Services |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops, and manufactures botanical therapeutics | Health Technology |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services Provides regulatory and drug development consulting services | Commercial Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmApprove LLC
PharmApprove LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies | Commercial Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Kalobios Pharmaceuticals, Inc. | Technology Services |
